Ronald L. Kirschner

Center and was an Assistant Professor at Southern Illinois University School of Medicine and has taught at the Illinois Institute of Technology in the Finance Department. While practicing medicine, he started 3 companies of his own in the healthcare field dealing with Nutrition, Managed Care, and Utilization Review. He has been a consultant on healthcare issues to the State government and on funding and market strategies to both entrepreneurs and early stage companies. He was the VP of Technology Development for CDIB Biotech, Inc., a Midwest Biotechnology Venture Fund (started by China Development Industrial Bank) where his roles was to assist in the discovery and funding of early stage biotechnology in the Midwest and Canada. He was principal in the funding decisions concerning, among others, Aegera Therapeutics, Immunicon (now Veridex), and VitaGen (now Vital Therapies, Inc.). He was active in advising local companies, e.g., Neuronautics, on options relating to funding opportunities and was involved with the Board of Directors for Phytoceutica.

Dr. Kirschner received his BA from Beloit College and was awarded his Medical Degree from St. Louis University. He has completed residencies in Emergency Medicine at the University of Chicago and in Anesthesia at West Virginia University. He received his MBA in Finance from DePaul University.